These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24399648)
1. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648 [TBL] [Abstract][Full Text] [Related]
2. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458 [TBL] [Abstract][Full Text] [Related]
3. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Shi FD; Zhang JY; Liu D; Rearden A; Elliot M; Nachtsheim D; Daniels T; Casiano CA; Heeb MJ; Chan EK; Tan EM Prostate; 2005 May; 63(3):252-8. PubMed ID: 15538718 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a panel of tumor-associated antigens in breast cancer. Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604 [TBL] [Abstract][Full Text] [Related]
5. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
6. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Hoshino I; Nagata M; Takiguchi N; Nabeya Y; Ikeda A; Yokoi S; Kuwajima A; Tagawa M; Matsushita K; Satoshi Y; Hideaki S Cancer Sci; 2017 Mar; 108(3):308-315. PubMed ID: 28064445 [TBL] [Abstract][Full Text] [Related]
7. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer. Wang P; Qin J; Ye H; Li L; Wang X; Zhang J J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321 [TBL] [Abstract][Full Text] [Related]
9. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118 [TBL] [Abstract][Full Text] [Related]
10. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011 [TBL] [Abstract][Full Text] [Related]
11. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer. Liu W; Li Y; Wang B; Dai L; Qian W; Zhang JY Scand J Immunol; 2015 Jun; 81(6):502-7. PubMed ID: 25721883 [TBL] [Abstract][Full Text] [Related]
14. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients. Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564 [TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596 [TBL] [Abstract][Full Text] [Related]
17. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades. Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402 [No Abstract] [Full Text] [Related]
18. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers. Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747 [TBL] [Abstract][Full Text] [Related]
19. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Liu X; Peng B; Li Y; Lei N; Li W; Zhang JY Mol Biol Rep; 2014 Nov; 41(11):7471-8. PubMed ID: 25086622 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]